ArticleFrontiers in oncology2026

Dynamics of the immune repertoire in recurrent, locally advanced NSCLC not amenable for definitive therapy and in stage IV disease receiving first-line chemotherapy.

Narumol Trachu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.